Thermo Fisher Scientific offers the Applied Biosystems TaqPath COVID-19 Pooling Kit, a real-time PCR multiplex test that enables the detection of SARS-CoV-2 in up to five samples simultaneously using a single detection kit for diagnostic population testing in areas with low incidence rates. Utilizing the kit to employ a pooling workflow can help streamline lab workflow and expedite results. The solution is highly sensitive with a level of detection down to 50 copies/mL and includes interpretive software that converts genetic analysis data into an end-user-friendly report to help reduce the risk of interpretation error. The kit contains the assays and controls for the qualitative detection of nucleic acid from SARS-CoV-2 in pooled upper respiratory specimens such as nasopharyngeal, oropharyngeal, nasal, and mid-turbinate swabs, and nasopharyngeal aspirate from individuals suspected of COVID-19.